Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jun;9(6):1429-1431.
doi: 10.21037/jtd.2017.05.68.

Novel centrifugal pump for heart failure patients: initial success and future challenges

Affiliations
Editorial

Novel centrifugal pump for heart failure patients: initial success and future challenges

Christina Feldmann et al. J Thorac Dis. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: JDS is PI of the HM3 CE mark and post CE mark study; JDS and GD are consultants for Abbott and Medtronic.

Figures

Figure 1
Figure 1
Prof. J.D. Schmitto, Hannover, Germany, with the worldwide first HeartMate 3 patient ~2.5 years after implantation.

Comment in

Comment on

  • A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
    Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, Walsh MN, Milano CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C; MOMENTUM 3 Investigators. Mehra MR, et al. N Engl J Med. 2017 Feb 2;376(5):440-450. doi: 10.1056/NEJMoa1610426. Epub 2016 Nov 16. N Engl J Med. 2017. PMID: 27959709 Clinical Trial.

References

    1. Schmitto JD, Hanke JS, Rojas SV, et al. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant 2015;34:858-60. 10.1016/j.healun.2015.03.001 - DOI - PubMed
    1. Netuka I, Sood P, Pya Y, et al. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. J Am Coll Cardiol 2015;66:2579-89. 10.1016/j.jacc.2015.09.083 - DOI - PubMed
    1. Zimpfer D, Netuka I, Schmitto JD, et al. Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes. Eur J Cardiothorac Surg 2016;50:548-54. 10.1093/ejcts/ezw169 - DOI - PubMed
    1. Krabatsch T, Netuka I, Schmitto JD, et al. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial. J Cardiothorac Surg 2017;12:23. 10.1186/s13019-017-0587-3 - DOI - PMC - PubMed
    1. Hanke JS, Dogan G, Rojas SV, et al. First experiences with HeartMate 3 follow-up and adverse events. J Thorac Cardiovasc Surg 2017. pii: S0022-5223(17)30178-2. - PubMed

LinkOut - more resources